Compare Stocks

→ Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLUA BlueRiver Acquisition	$11.00 +0.2%	$10.85	$10.15 ▼ $12.00	$96.03M	N/A	34,573 shs	200 shs
BWAY BrainsWay	$5.56 +5.9%	$5.60	$1.38 ▼ $7.61	$92.52M	1.2	114,767 shs	36,855 shs
KRMD KORU Medical Systems	$2.25 +3.7%	$2.19	$1.98 ▼ $4.30	$102.85M	0.53	96,529 shs	316,334 shs
MGRM Monogram Orthopaedics	$1.95 -5.8%	$2.42	$1.53 ▼ $48.99	$61.68M	N/A	179,870 shs	222,774 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLUA BlueRiver Acquisition	+0.18%	+0.09%	+0.92%	+1.57%	+7.84%
BWAY BrainsWay	+5.90%	+10.54%	+0.91%	-3.81%	+270.67%
KRMD KORU Medical Systems	+3.69%	+2.27%	-6.25%	+6.64%	-44.44%
MGRM Monogram Orthopaedics	-5.57%	-16.31%	-17.37%	-40.46%	+194,999,900.00%

Elon’s New Device is About to Shock the World (Ad)

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BWAY BrainsWay	1.4125 of 5 stars	3.3	3.0	0.0	0.0	0.8	0.8	0.6
KRMD KORU Medical Systems	1.978 of 5 stars	3.5	1.0	0.0	0.0	2.4	2.5	0.6
MGRM Monogram Orthopaedics	0.1638 of 5 stars	0.0	3.0	0.0	0.0	1.7	1.7	0.0

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A
BWAY BrainsWay	2.67	Moderate Buy	$7.00	25.90% Upside
KRMD KORU Medical Systems	3.00	Buy	$3.50	55.56% Upside
MGRM Monogram Orthopaedics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest BLUA, KRMD, BWAY, and MGRM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/14/2024	KRMD KORU Medical Systems	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00
3/11/2024	BWAY BrainsWay	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 5/2/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A	($0.72) per share	N/A
BWAY BrainsWay	$31.78M	2.91	N/A	N/A	$2.50 per share	2.22
KRMD KORU Medical Systems	$28.52M	3.61	N/A	N/A	$0.45 per share	5.00
MGRM Monogram Orthopaedics	$370K	166.70	N/A	N/A	$0.43 per share	4.53

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLUA BlueRiver Acquisition	-$5.28M	N/A	0.00	∞	N/A	N/A	N/A	-25.55%	N/A
BWAY BrainsWay	-$4.20M	-$0.13	N/A	69.50	N/A	-13.20%	-10.05%	-6.88%	5/8/2024 (Confirmed)
KRMD KORU Medical Systems	-$13.74M	-$0.29	N/A	N/A	N/A	-48.18%	-27.82%	-21.30%	N/A
MGRM Monogram Orthopaedics	-$13.74M	-$0.79	N/A	N/A	N/A	N/A	-143.70%	-83.17%	6/4/2024 (Estimated)

Latest BLUA, KRMD, BWAY, and MGRM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2024	N/A	BWAY BrainsWay	-$0.02	N/A	+$0.02	N/A	N/A	N/A
3/15/2024	Q4 2023	MGRM Monogram Orthopaedics	N/A	-$0.09	-$0.09	-$0.09	N/A	$0.37 million
3/13/2024	Q4 2023	KRMD KORU Medical Systems	-$0.04	-$0.02	+$0.02	$0.12	$7.01 million	$7.19 million
3/6/2024	12/31/2023	BWAY BrainsWay	-$0.03	-$0.01	+$0.02	N/A	$8.40 million	$9.03 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A	N/A
BWAY BrainsWay	N/A	N/A	N/A	N/A	N/A
KRMD KORU Medical Systems	N/A	N/A	N/A	N/A	N/A
MGRM Monogram Orthopaedics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLUA BlueRiver Acquisition	N/A	0.01	0.01
BWAY BrainsWay	N/A	5.68	5.30
KRMD KORU Medical Systems	0.02	4.55	3.77
MGRM Monogram Orthopaedics	N/A	5.19	5.19

Ownership

Institutional Ownership

Company	Institutional Ownership
BLUA BlueRiver Acquisition	22.34%
BWAY BrainsWay	30.11%
KRMD KORU Medical Systems	58.60%
MGRM Monogram Orthopaedics	0.45%

Insider Ownership

Company	Insider Ownership
BLUA BlueRiver Acquisition	78.98%
BWAY BrainsWay	19.00%
KRMD KORU Medical Systems	21.70%
MGRM Monogram Orthopaedics	32.10%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BLUA BlueRiver Acquisition	3	8.73 million	1.84 million	Not Optionable
BWAY BrainsWay	134	16.64 million	13.48 million	Not Optionable
KRMD KORU Medical Systems	82	45.71 million	35.79 million	Optionable
MGRM Monogram Orthopaedics	28	31.63 million	21.48 million	Not Optionable

BLUA, KRMD, BWAY, and MGRM Headlines

Source	Headline
	Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth? finance.yahoo.com - May 1 at 11:05 AM
	Monogram Provides Regulatory Update Following Meeting with FDA accesswire.com - May 1 at 8:00 AM
	U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.01% msn.com - April 13 at 9:17 AM
	Monogram Orthopaedics joins NVIDIA Inception program investing.com - April 13 at 12:31 AM
	MONOGRAM ORTHOPAEDICS INC: Monogram Accepted to NVIDIA Inception Program finanznachrichten.de - April 11 at 2:27 PM
	Monogram Accepted to NVIDIA Inception Program accesswire.com - April 11 at 1:20 PM
	Individual investors who hold 62% of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) gained 13%, insiders profited as well finance.yahoo.com - March 22 at 7:30 PM
	Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Q4 2023 Earnings Call Transcript insidermonkey.com - March 22 at 7:30 PM
	When Can We Expect A Profit From Monogram Orthopaedics, Inc. (NASDAQ:MGRM)? finance.yahoo.com - March 21 at 7:34 AM
	MGRM: Initiation of medical device company developing a product solution architecture to enable patient-optimized orthopedic implants by linking 3D printing and robotics. finance.yahoo.com - March 20 at 4:09 PM
	Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time finance.yahoo.com - March 20 at 4:09 PM
	MONOGRAM ORTHOPAEDICS INC: Monogram Orthopaedics Reports Full Year 2023 Financial Results finanznachrichten.de - March 15 at 12:23 PM
	Monogram Unchanged at Friday Open msn.com - March 15 at 12:23 PM
	Monogram Orthopaedics Reports Full Year 2023 Financial Results accesswire.com - March 15 at 8:30 AM
	Monogram Orthopaedics Stock (NASDAQ:MGRM) Earnings Dates and Earning Calls benzinga.com - February 22 at 2:07 PM
	Monogram Orthopaedics Inc.: Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting finanznachrichten.de - February 12 at 3:42 PM
	Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting finance.yahoo.com - February 12 at 10:41 AM
	Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024 finance.yahoo.com - January 24 at 1:15 PM
	Insiders own 26% of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) shares but retail investors control 60% of the company finance.yahoo.com - December 31 at 11:41 AM
	Monogram Orthopaedics to Reschedule Robotic Product Demo Live Stream finance.yahoo.com - December 14 at 1:21 PM
	Monogram Orthopaedics Stock (NASDAQ:MGRM), Analyst Ratings, Price Targets, Predictions benzinga.com - December 8 at 1:36 PM
	Monogram Orthopedics’ Surgical Robot Now Reality As Company Delivers First System finance.yahoo.com - December 8 at 1:36 PM
	Monogram Orthopaedics Stock (NASDAQ:MGRM) Dividends: History, Yield and Dates benzinga.com - December 8 at 1:36 PM
	Monogram Orthopaedics to Host Robotic Product Demo Live Stream on Thursday, December 14, 2023 at 11:00 a.m. Eastern Time finance.yahoo.com - November 30 at 9:26 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BlueRiver Acquisition

NYSE:BLUA

BlueRiver Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of technology, media, telecom, and entertainment industries. The company was incorporated in 2020 and is based in San Antonio, Texas.

BrainsWay

NASDAQ:BWAY

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

KORU Medical Systems

NASDAQ:KRMD

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Monogram Orthopaedics

NASDAQ:MGRM

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial